Claudin Expression in Triple Negative and ER-Positive Breast Carcinoma

被引：0
|
作者：
Malik, M. A. [1 ]
Cohen, C. [1 ]
Adams, A. [1 ]
Wang, J. [1 ]
Oprea, G. M. [1 ]
机构：
[1] Emory Univ Hosp, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
224
引用
收藏
页码：56A / 56A
页数：1
相关论文
共 50 条
  • [1] Claudin Expression in Triple Negative and ER-Positive Breast Carcinoma
    Malik, M. A.
    Cohen, C.
    Adams, A.
    Wang, J.
    Oprea, G. M.
    MODERN PATHOLOGY, 2013, 26 : 56A - 56A
  • [2] Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers
    Liu, Dingxie
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 95 - 105
  • [3] Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers
    Dingxie Liu
    Breast Cancer Research and Treatment, 2020, 183 : 95 - 105
  • [4] In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer
    Bouchmaa, Najat
    Ben Mrid, Reda
    Bouargalne, Youssef
    Ajouaoi, Sana
    Cacciola, Francesco
    El Fatimy, Rachid
    Nhiri, Mohamed
    Zyad, Abdelmajid
    PLOS ONE, 2023, 18 (02):
  • [5] Genetic Copy Number Differences Between ER-positive and ER-negative Human Breast Carcinoma
    Fang, M.
    Toher, J.
    Morgan, M.
    Davison, J.
    Tannenbaum, S.
    Claffey, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 666 - 666
  • [6] New Treatment Options in ER-Positive, HER2-Positive and Triple-Negative Breast Cancer
    Steger, Guenther
    Bell, Richard
    Cameron, David
    Dent, Rebecca A.
    Jackisch, Christian
    BREAST CARE, 2013, 8 (02) : 155 - 157
  • [7] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [8] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    Breast Cancer Research, 7
  • [9] Window of opportunity trial of neoadjuvant olaparib and durvalumab for triple negative or low ER-positive breast cancer
    Im, Seock-Ah
    Lee, Kyung-Hun
    Min, Ahrum
    Lee, Daewon
    Kim, Tae Yong
    Ryu, Han Suk
    Koh, Jiwon
    Cheon, Gi-Jeong
    Shin, Yoon-Jung
    Kim, Yujin
    Moon, Hyeong-Gon
    Han, Wonshik
    Lee, Han-Byoel
    Diolaiti, Morgan
    Quigley, David
    Ashworth, Alan
    Cho, Nariya
    CANCER RESEARCH, 2022, 82 (04)
  • [10] HIGH EXPRESSION OF CLAUDIN 4 IN TRIPLE NEGATIVE BREAST CANCER
    Kang, Sun Hee
    Kim, H.
    BREAST, 2013, 22 : S30 - S30
12345